BiotechTube
Home/Soligenix/Richard Straube, MD
RS

Richard Straube, MD

Senior Vice President, Chief Medical Officer

Soligenix

Therapeutic Areas

OncologyInflammation/ImmunologyInfectious DiseaseBiodefense

Soligenix Pipeline

DrugIndicationPhase
SGX301Cutaneous T-Cell Lymphoma (CTCL)Phase 3
SGX942Oral Mucositis in Head & Neck CancerPhase 3
SGX945Behçet's Disease (Oral Ulcers)Phase 2a
SGX302Psoriasis (Plaque)Phase 2a
RiVax®Prevention of Ricin IntoxicationPhase 1b
SGX204Filovirus (Ebola/Marburg) VaccinePreclinical
Dengue VaccinePrevention of Dengue FeverPreclinical

Leadership Team at Soligenix

CJ
Christopher J. Schaber, PhD
President, Chief Executive Officer, Director
JL
Jonathan L. Guarino, CPA
Chief Financial Officer
OD
Oreola Donini, PhD
Senior Vice President, Chief Scientific Officer
DL
Diane L. Parks
Vice President, Regulatory Affairs
View full Soligenix profile